GPR50 Antibody - Azide and BSA Free

Western Blot: GPR50 Antibody [H00009248-B01P]

GPR50-Antibody-Western-Blot-H00009248-B01P-img0005.jpg

Western Blot: GPR50 Antibody [H00009248-B01P]

GPR50-Antibody-Western-Blot-H00009248-B01P-img0006.jpg

Western Blot: GPR50 Antibody [H00009248-B01P] -

Western Blot: GPR50 Antibody [H00009248-B01P] - GPR50 phosphorylate & activate T betaRI independently of T betaRII. a SNU638 cells were transfected with the indicated plasmids, stimulated for 1 h with TGF beta (2 ng/mL) & pretreated or not overnight with SB431542 at 10 µM. p-Smad3 & total Smad3 levels & expression of transfected plasmids were determined by western blot in cell lysates. b Co-immunoprecipitation of GRP50 & T betaRI in lysates of SNU638 cells expressing HA-T betaRI alone or together with GPR50 delta4. Total lysates were used as expression control (c) SNU638 cells were transfected with the indicated plasmids, stimulated TGF beta (2 ng/mL, 1 h). Total T betaRI was immunoprecipitated with anti-Flag antibody & immunoblotted for anti-T betaRIp-S165. Below, the same blot was immunoblotted with anti-Flag to show the amount of T betaRI precipitation in cell lysates. d Phospho-Smad3 & Smad2/3 levels were determined in lysates of SNU638 cells stimulated or not with TGF beta (2 ng/mL, 1 h) & expressing the indicated proteins (as verified by western blot). The myc-MT2 melatonin receptor & the myc-MT2-GPR50Cter served as negative controls. Representative results are shown for all the panels. Similar results were obtained in at least two additional experiments. See also Supplementary Fig. 4 Image collected & cropped by CiteAb from the following publication (https://www.nature.com/articles/s41467-018-03609-x), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: GPR50 Antibody [H00009248-B01P] -

Western Blot: GPR50 Antibody [H00009248-B01P] - GPR50 phosphorylate & activate T betaRI independently of T betaRII. a SNU638 cells were transfected with the indicated plasmids, stimulated for 1 h with TGF beta (2 ng/mL) & pretreated or not overnight with SB431542 at 10 µM. p-Smad3 & total Smad3 levels & expression of transfected plasmids were determined by western blot in cell lysates. b Co-immunoprecipitation of GRP50 & T betaRI in lysates of SNU638 cells expressing HA-T betaRI alone or together with GPR50 delta4. Total lysates were used as expression control (c) SNU638 cells were transfected with the indicated plasmids, stimulated TGF beta (2 ng/mL, 1 h). Total T betaRI was immunoprecipitated with anti-Flag antibody & immunoblotted for anti-T betaRIp-S165. Below, the same blot was immunoblotted with anti-Flag to show the amount of T betaRI precipitation in cell lysates. d Phospho-Smad3 & Smad2/3 levels were determined in lysates of SNU638 cells stimulated or not with TGF beta (2 ng/mL, 1 h) & expressing the indicated proteins (as verified by western blot). The myc-MT2 melatonin receptor & the myc-MT2-GPR50Cter served as negative controls. Representative results are shown for all the panels. Similar results were obtained in at least two additional experiments. See also Supplementary Fig. 4 Image collected & cropped by CiteAb from the following publication (https://www.nature.com/articles/s41467-018-03609-x), licensed under a CC-BY license. Not internally tested by Novus Biologicals.